In particular, when combined with other therapeutic strategies, NEK2 inhibition sensitizes tumor cells to traditional chemotherapy and radiotherapy, making it a promising strategy for cancer therapy by integrating chemotherapy, targeted therapy, and immunotherapy [83]. Here, NEK2 is linked to neoplasm.